Gene: MARCHF5
Official Full Name: membrane associated ring-CH-type finger 5provided by HGNC
Gene Summary: MARCH5 is a ubiquitin ligase of the mitochondrial outer membrane that plays a role in the control of mitochondrial morphology by regulating mitofusin-2 (MFN2; MIM 608507) and DRP1 (DNM1L; MIM 603850) (Nakamura et al., 2006 [PubMed 16936636]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02201 | MARCHF5 Knockout cell line (HeLa) | Human | MARCHF5 | 1:3~1:6 | Negative | Online Inquiry |
KO02202 | MARCHF5 Knockout cell line (HCT 116) | Human | MARCHF5 | 1:2~1:4 | Negative | Online Inquiry |
KO02203 | MARCHF5 Knockout cell line (HEK293) | Human | MARCHF5 | 1:3~1:6 | Negative | Online Inquiry |
KO02204 | MARCHF5 Knockout cell line (A549) | Human | MARCHF5 | 1:3~1:4 | Negative | Online Inquiry |
MARCHF5 Gene Knockout Cell Lines are engineered cellular systems designed to specifically disrupt the MARCHF5 gene, which encodes an E3 ubiquitin ligase involved in regulating immune responses and cellular signaling pathways. This product utilizes CRISPR/Cas9 technology to create precise genomic alterations, enabling researchers to study the functional consequences of MARCHF5 deficiency in a controlled environment. The knockout of this gene allows for an in-depth analysis of its role in various biological processes, particularly in the areas of immune evasion and cellular growth regulation.
The key mechanism behind MARCHF5 knockout cell lines is the targeted disruption of the MARCHF5 gene, which leads to altered expression of proteins involved in immune modulation. This results in changes to critical cellular functions such as apoptosis, proliferation, and cytokine production, making these cell lines invaluable for dissecting the pathways associated with immune system disorders and potential therapeutic targets for diseases like cancer and autoimmune conditions.
The scientific importance of MARCHF5 knockout cell lines lies in their applicability in both basic research and clinical settings. Researchers can utilize these cell lines to further our understanding of how MARCHF5 contributes to disease mechanisms and to test novel therapeutic interventions that may restore or inhibit its function. Additionally, the unique characteristics of these cell lines facilitate high-throughput screening endeavors aimed at identifying compounds that can modulate the MARCHF5 pathway.
What sets MARCHF5 Gene Knockout Cell Lines apart from alternatives is their high reliability and reproducibility, thanks to the precise CRISPR/Cas9 editing protocol employed during development. Moreover, they come with comprehensive documentation and support, ensuring that researchers can readily incorporate them into their experimental workflows with confidence.
For researchers and clinicians, the ability to study the implications of MARCHF5 gene knockout opens up a range of opportunities to uncover new insights into cellular behavior and immune response, rendering this product an essential tool in the quest for innovative treatments. Our company prides itself on cutting-edge advancements in biological products and a commitment to providing high-quality, expertly developed tools that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.